TY - JOUR
T1 - Radiation Therapy Toxicity to the Skin
AU - FitzGerald, T. J.
AU - Jodoin, Maryann Bishop
AU - Tillman, Gayle
AU - Aronowitz, Jesse
AU - Pieters, Richard
AU - Balducci, Susan
AU - Meyer, Joshua
AU - Cicchetti, M. Giulia
AU - Kadish, Sidney
AU - McCauley, Shelagh
AU - Sawicka, Joanna
AU - Urie, Marcia
AU - Lo, Y. C.
AU - Mayo, Charles
AU - Ulin, Kenneth
AU - Ding, Linda
AU - Britton, Maureen
AU - Huang, Jiayi
AU - Arous, Edward
PY - 2008/1
Y1 - 2008/1
N2 - Radiation therapy has been integral to cancer patient care. The skin is an intentional and unintentional target of therapy, and is sensitive to the volume of normal tissue in the radiation therapy treatment field, daily treatment dose (fractionation), and total treatment dose. We must understand the relationship of these factors to patient outcome as we move toward hypofractionation treatment strategies (radiosurgery). Chemotherapy agents and prescription medications may influence therapy-associated sequelae. Understanding this may prevent significant injury and discomfort. This article reviews established platforms of radiation therapy and sequelae associated with skin therapy. Interactions with other agents and possible predisposition to sequelae are reviewed. Skin cancer resulting from treatment and disease processes associated with possible limited outcome are also reviewed.
AB - Radiation therapy has been integral to cancer patient care. The skin is an intentional and unintentional target of therapy, and is sensitive to the volume of normal tissue in the radiation therapy treatment field, daily treatment dose (fractionation), and total treatment dose. We must understand the relationship of these factors to patient outcome as we move toward hypofractionation treatment strategies (radiosurgery). Chemotherapy agents and prescription medications may influence therapy-associated sequelae. Understanding this may prevent significant injury and discomfort. This article reviews established platforms of radiation therapy and sequelae associated with skin therapy. Interactions with other agents and possible predisposition to sequelae are reviewed. Skin cancer resulting from treatment and disease processes associated with possible limited outcome are also reviewed.
UR - http://www.scopus.com/inward/record.url?scp=36048954801&partnerID=8YFLogxK
U2 - 10.1016/j.det.2007.08.005
DO - 10.1016/j.det.2007.08.005
M3 - Review article
C2 - 18023776
AN - SCOPUS:36048954801
SN - 0733-8635
VL - 26
SP - 161
EP - 172
JO - Dermatologic Clinics
JF - Dermatologic Clinics
IS - 1
ER -